Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients

Completed · Phase 2

Conditions studied: Acromegaly

In brief

5 month study comparing SOM230 s.c. and Sandostatin s.c. in acromegalic patients.

Key facts

Study ID
NCT00088582
Run by
Novartis Pharmaceuticals
People needed
62
Starts
2004-03-01
Last updated by the study team
2016-11-07

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.